Description
Donormil (Doxylamine Succinate) Coated Tablets 15 mg. №30 Vial
Ingredients
Active ingredient: Doxylamine succinate 15 mg per coated tablet.
Mechanism of Action
Doxylamine succinate exerts its pharmacological effects as a first-generation antihistamine by antagonizing histamine receptors, leading to sedative and hypnotic actions.
Indications for Use
Donormil tablets are indicated for the short-term treatment of insomnia characterized by difficulty falling asleep.
Contraindications
Do not use Donormil tablets if you are allergic to doxylamine succinate, have narrow-angle glaucoma, severe urinary retention, or severe liver disease.
Side Effects
Common side effects of Donormil may include drowsiness, dry mouth, blurred vision, and gastrointestinal disturbances.
Usage Instructions
Recommended dosage: Take 1 tablet orally before bedtime with water. Do not exceed the recommended dose.
Benefits Compared to Analogues
Donormil offers a well-established sedative effect with a proven safety profile, making it a preferred choice for the short-term management of insomnia compared to other sedative-hypnotic agents.
Suitable Patient Groups
Donormil is suitable for adult patients experiencing transient insomnia and difficulty initiating sleep. Caution is advised in elderly patients due to the potential for increased sensitivity to anticholinergic effects.
Storage and Shelf Life
- Storage: Keep Donormil tablets at room temperature, protected from light and moisture.
- Shelf life: Check the expiration date on the packaging and do not use after the specified date.
Packaging Description
Donormil tablets are supplied in a vial containing 30 coated tablets, each providing 15 mg of doxylamine succinate.
Clinical Evidence and Proven Effectiveness
Doxylamine succinate, the active ingredient in Donormil tablets, has been extensively studied for its efficacy in improving sleep parameters in individuals with insomnia. Clinical trials have consistently demonstrated the reduction in sleep onset latency and improvement in sleep quality with doxylamine succinate use.
